PREVENTIVE OR THERAPEUTIC AGENT FOR STROKE OR SEQUELAE OF STROKE COMPRISING AS MAIN COMPONENT SALVIANOLIC ACID B OR THE LIKE

摘要

[PROBLEMS] To provide a novel preventive or therapeutic agent for stroke or sequelae of stroke. [MEANS FOR SOLVING PROBLEMS] A preventive or therapeutic agent for stroke or sequelae of stroke comprising as a main component, a compound selected from salvianolic acid B, its prodrugs, and their pharmaceutically acceptable salts and hydrates has been developed. For example, by being administered at a dose of 22.5 mg/kg once daily five times a week, salvianolic acid B reduces the occurrence of stroke by 30% and even in the case where stroke occurs, the sequelae are mild.